[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-294399-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-294399-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","naplex-osteoporosis-medical-crosswords-and-osteoporosis-drugclass-clues","NAPLEX-Osteoporosis - Medical crosswords and osteoporosis drug/class clues","","NAPLEX-Osteoporosis is a crossword-style medical review focused on osteoporosis therapy. It provides clues for major osteoporosis drug classes and mechanisms, including agents targeting RANKL and osteoclast activity, anabolic bonebuilding medications, first-line treatments, and bisphosphonate-related complications. The material also covers diagnostic and risk concepts such as bone mineral density scanning, a clinical risk factor scoring system, and T-score interpretation. Additional clues address estrogen receptor–selective therapy, zoledronic acid toxicity, jaw osteonecrosis, calcium forms, vitamin D, and dosing approaches.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/exam/","Exam",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/naplex-osteoporosis-medical-crosswords-and-osteoporosis-drugclass-clues/294399/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/naplex-osteoporosis-medical-crosswords-and-osteoporosis-drugclass-clues/294399.png","ImageObject",300,407,{"name":42,"@type":43},"Dozel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-17",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which medications target RANKL in osteoporosis therapy?","Question",{"text":63,"@type":64},"The clue describes a monoclonal antibody that targets RANKL and prevents activating RANK, reducing bone resorption and increasing bone strength.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the bone density threshold that indicates osteoporosis on the T-score assessment?",{"text":68,"@type":64},"A value of -2.5 or lower is indicative of osteoporosis with this assessment.",{"name":70,"@type":61,"acceptedAnswer":71},"What rare but important adverse effect is associated with bisphosphonates?",{"text":72,"@type":64},"A rare adverse effect affecting the jaw is identified as a bisphosphonate complication.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},294399,1789684731,{"code":4,"msg":82,"data":83},"success",[84,88,92,95,100,105,110,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":93,"slug":94},70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":33,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":26,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":80,"read_time":96},962085662650,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","NAPLEX-Osteoporosis  \n1  \n2  \n3  \n4  \n5  \n6  \n7  \n8  \n9  \n10  \n11  \n12  \n13  \n14  \n15  \n16  \n17  \n18  \n19  \n20  \n\n|  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- |\n\nAcross  \n3. Carries a black box warning for osteosarcoma  \n6. Lower efficacy than first-line agents, may be beneficial for breast cancer, and increases the risk for DVT/stroke  \n10. Monoclonal antibody that targets RANKL and prevents activating RANK which is important in activating the action of osteoclasts; thus reducing bone resorption and increasing bone strength (brand name)  \n11. Brand name bisphosphonate that has an IV and oral formulation  \n12. Scoring system that includes clinical risk factors and is used to determine if a patient should begin osteoporosis therapy  \n13. Stimulates estrogen receptors selectively in bone tissue leading to an increase in bone strength (brand name)  \n16. Abbreviation for potential complication in patients taking zoledronic acid  \nDown  \n1. Brand name medication that has anabolic (bonebuilding) effects by stimulating osteoblasts  \n2. Class of medication that is most often used firstline for osteoporosis  \n4. Beneficial for osteoporosis but avoided due to the risk of cancer and blood clots  \n5. Scan that assesses bone mineral density  \n7. Potential toxicity associated with zoledronic acid  \n8. Opposes the action of parathyroid hormone and inhibits the activity of osteoclasts which results inan increase in bone strength  \n9. This medication inhibits osteoclasts; osteoclasts breakdown bone to help pull calcium into the bloodstream  \n14. A value of-2.5 or lower is indicative of osteoporosis with this assessment  \n15. Nasal spray that can help with osteoporosis and compression fracture pain  \n17. Important supplement to consider in osteoporotic patients  \n18. Rare adverse effect ofbisphosphonates that affects the jaw  \n19. This form of calcium is better absorbed than carbonate  \n20. Twice yearly injection that can cause low calcium and muscle pain as adverse effects","cbCaim3pDbSIVQjY","https://ap.wps.com/l/cbCaim3pDbSIVQjY","pdf",88947,"English","# Across\n## Medication and diagnostic clues\n# Down\n## Treatment, complications, and supplements","[{\"question\":\"Which medications target RANKL in osteoporosis therapy?\",\"answer\":\"The clue describes a monoclonal antibody that targets RANKL and prevents activating RANK, reducing bone resorption and increasing bone strength.\"},{\"question\":\"What is the bone density threshold that indicates osteoporosis on the T-score assessment?\",\"answer\":\"A value of -2.5 or lower is indicative of osteoporosis with this assessment.\"},{\"question\":\"What rare but important adverse effect is associated with bisphosphonates?\",\"answer\":\"A rare adverse effect affecting the jaw is identified as a bisphosphonate complication.\"}]","NAPLEX-Osteoporosis - Medical crosswords and osteoporosis drug/class clues | PDF"]